Opportunity Information: Apply for RFA NR 13 004
Apply for RFA NR 13 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Limited Competition Palliative Care Research Co Operative (PCRC) (U24)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research.
- This funding opportunity was created on Nov 21, 2012 and posted on Nov 21, 2012.
- Applicants must submit their applications by Jan 23, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition Palliative Care Research Co Operative (PCRC) (U24) funding opportunity, issued by the National Institute of Nursing Research (NINR) within the National Institutes of Health (NIH), was designed to continue federal support for the Palliative Care Research Cooperative (PCRC). Its central aim was to strengthen and maintain the PCRC as a shared national research infrastructure and set of resources that can enable high impact palliative care and end-of-life (PCEOL) studies. A key emphasis of this announcement was speed and scalability: it sought to make it possible to launch important palliative care research quickly and to carry it out with larger participant samples across multiple clinical sites, which is often necessary to produce results that are robust, generalizable, and useful for real-world care settings.
This opportunity was offered as a cooperative agreement (U24), which typically signals an NIH-supported research resource or infrastructure project where substantial programmatic involvement from the NIH is expected during the award. In practice, that means the funded cooperative would not simply run isolated studies; it would provide organized research and resource activities that multiple investigators and sites could leverage, helping streamline common tasks that slow palliative care trials and other PCEOL studies, such as multi-site coordination, harmonized procedures, and access to shared tools and expertise. The overall intent was to support "cutting edge" palliative care research that benefits from coordinated networks and centralized support rather than relying on single-site efforts.
From an administrative standpoint, the FOA number was RFA-NR-13-004, and it fell under the discretionary category with an activity focus in education and health. The associated CFDA listing was 93.361 (Nursing Research). The total estimated funding available was listed as $2,000,000, and there was no cost sharing or matching requirement, meaning applicants were not required to contribute a specific non-federal share as a condition of the award.
Eligibility was limited and described as a "limited competition" opportunity, indicating that only certain applicants identified or otherwise qualified under NIH criteria could apply (the announcement points readers to additional eligibility information in the full text). Importantly, foreign participation was restricted: non-U.S. entities (foreign institutions) were not eligible to apply, non-U.S. components of U.S. organizations were not eligible, and foreign components as defined in the NIH Grants Policy Statement were not allowed. In other words, the award was intended to be carried out entirely within eligible U.S.-based organizational structures.
The timeline for the opportunity reflects a specific, time-limited solicitation. It was posted and created on November 21, 2012, with an original and current closing date of January 23, 2013, and an archive date of February 23, 2013. The full announcement was made available through the NIH grants guide at the provided link (http://grants.nih.gov/grants/guide/rfa-files/RFA-NR-13-004.html). For technical issues accessing or linking to the announcement, applicants were directed to contact the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled the Limited Competition Palliative Care Research Co Operative (PCRC) (U24) funding opportunity.
Which agency issued this funding opportunity?
It was issued by the National Institute of Nursing Research (NINR) within the National Institutes of Health (NIH).
What is the FOA number for this announcement?
The FOA number is RFA-NR-13-004.
What is the primary purpose of this opportunity?
Its central purpose was to continue federal support for the Palliative Care Research Cooperative (PCRC) and to strengthen and maintain the PCRC as a shared national research infrastructure and set of resources for high-impact palliative care and end-of-life (PCEOL) studies.
What kinds of research does the PCRC infrastructure support?
The infrastructure is intended to enable palliative care and end-of-life (PCEOL) studies, especially those that benefit from coordinated networks and centralized support rather than single-site efforts.
What was a key emphasis of the announcement?
A key emphasis was speed and scalability: enabling important palliative care research to launch quickly and to be conducted with larger participant samples across multiple clinical sites.
Why does the announcement emphasize multi-site studies and larger samples?
Because larger, multi-site studies are often needed to produce results that are robust, generalizable, and useful for real-world care settings.
What funding mechanism is used (what does U24 mean in this context)?
The opportunity used a cooperative agreement mechanism (U24), which typically indicates an NIH-supported research resource or infrastructure project with substantial programmatic involvement from NIH during the award.
What does "substantial programmatic involvement" from NIH imply for awardees?
Based on the description provided, it means the funded cooperative would operate as organized research and resource infrastructure (not simply isolated studies), and NIH is expected to be substantially involved programmatically during the award.
Is this meant to fund individual, isolated research studies?
No. The intent described is to support organized research and resource activities that multiple investigators and sites can leverage, helping streamline common tasks that slow palliative care trials and other PCEOL studies.
What types of shared support activities are implied by this infrastructure focus?
The description highlights support that can streamline tasks such as multi-site coordination, harmonized procedures, and access to shared tools and expertise.
How is this opportunity categorized?
It was listed under the discretionary category with an activity focus in education and health.
What is the associated CFDA number?
The associated CFDA listing is 93.361 (Nursing Research).
How much total funding was estimated to be available?
The total estimated funding available was listed as $2,000,000.
Is cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement, meaning applicants were not required to contribute a specific non-federal share as a condition of the award.
Who is eligible to apply?
Eligibility was limited under a "limited competition" approach, meaning only certain applicants identified or otherwise qualified under NIH criteria could apply. The announcement directs readers to additional eligibility information in the full text.
What does "limited competition" mean here?
It means the competition was not open to all potential applicants; only specific applicants meeting NIH-specified eligibility conditions (as described in the full announcement text) could apply.
Are foreign (non-U.S.) institutions eligible to apply?
No. Non-U.S. entities (foreign institutions) were not eligible to apply.
Can a U.S. organization apply if it has a non-U.S. component?
No. The opportunity states that non-U.S. components of U.S. organizations were not eligible.
Are foreign components allowed under NIH policy definitions?
No. Foreign components (as defined in the NIH Grants Policy Statement) were not allowed.
Does the work need to be carried out entirely within the United States?
Yes, as described: the award was intended to be carried out entirely within eligible U.S.-based organizational structures, with foreign participation restricted as noted.
When was the opportunity posted?
It was posted (created) on November 21, 2012.
What was the application due date?
The original and current closing date was January 23, 2013.
When was the opportunity archived?
The archive date was February 23, 2013.
Where can applicants find the full announcement text?
The full announcement was made available through the NIH grants guide at: http://grants.nih.gov/grants/guide/rfa-files/RFA-NR-13-004.html
Who should be contacted for technical problems accessing or linking to the announcement?
For technical issues accessing or linking to the announcement, applicants were directed to contact the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Is this opportunity still open?
No. The closing date listed is January 23, 2013, and an archive date of February 23, 2013 is provided, indicating it is no longer an active solicitation.
Browse more opportunities from the same category: Education Health
Next opportunity: Trans Agency Research Consortium for Trauma Induced Coagulopathy (TACTIC) (UM1)
Previous opportunity: Research and data collection for sage grouse habitat
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NR 13 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NR 13 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 13 036 Funding Number: PAR 13 036 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA NS 13 007 Funding Number: RFA NS 13 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS and Cancer Specimen Resource (ACSR) (UM1) Apply for RFA CA 13 005 Funding Number: RFA CA 13 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R01) Apply for PAR 13 048 Funding Number: PAR 13 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R21) Apply for PAR 13 049 Funding Number: PAR 13 049 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pain in Aging (R01) Apply for PA 13 058 Funding Number: PA 13 058 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pain in Aging (R21) Apply for PA 13 059 Funding Number: PA 13 059 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pain in Aging (R03) Apply for PA 13 060 Funding Number: PA 13 060 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Administrative Supplements to NCI Funded Research Projects Funding to Advance Research on Cancers in Women (Admin Supp) Apply for PAR 13 067 Funding Number: PAR 13 067 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20) Apply for PAR 13 068 Funding Number: PAR 13 068 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R21) Apply for PAR 13 054 Funding Number: PAR 13 054 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Dissemination and Implementation Research in Health (R03) Apply for PAR 13 056 Funding Number: PAR 13 056 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Behavioral Integrative Treatment Development Program (R34) Apply for PA 13 078 Funding Number: PA 13 078 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Behavioral Integrative Treatment Development Program (R01) Apply for PA 13 077 Funding Number: PA 13 077 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Behavioral Integrative Treatment Development Program (R03) Apply for PA 13 079 Funding Number: PA 13 079 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Accelerating the Pace of Drug Abuse Research Using Existing Data (R01) Apply for PAR 13 080 Funding Number: PAR 13 080 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Bridging the Gap Between Cancer Mechanism and Population Science (U01) Apply for PAR 13 081 Funding Number: PAR 13 081 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25) Apply for PAR 13 084 Funding Number: PAR 13 084 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 13 086 Funding Number: PAR 13 086 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Apply for PAR 13 087 Funding Number: PAR 13 087 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NR 13 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.